23 Jul, 2026
According to Straits Research, the global ureteroscope market size was valued at $1.38 billion in 2025 and is projected to grow from $1.46 billion in 2026 to $2.26 billion by 2034, growing at a CAGR of 5.62% during the forecast period 2026–2034.
A major factor driving the growth of the global ureteroscope market is the increasing incidence of urolithiasis, largely attributed to inadequate hydration, excessive salt consumption, and sedentary habits. The National Kidney Foundation reports that more than 500,000 Americans visit emergency departments annually due to kidney stones, with global prevalence rates reaching up to 15% among adults. This trend has fueled the need for minimally invasive solutions like ureteroscopy.
Furthermore, continuous technological innovations, such as device miniaturization, enhanced deflection, and high-definition imaging, are improving procedural efficiency and patient outcomes. The market is also benefiting from the rapid development of healthcare infrastructure, particularly in emerging markets like India and China, where governments are making substantial investments in advanced urology technologies. Combined with growing public awareness about the importance of early detection and treatment of urological conditions, these factors are significantly accelerating the expansion of the ureteroscope market worldwide.
A major factor driving the global market is the growing elderly population. With age, the likelihood of developing urological conditions, such as kidney stones, benign prostatic hyperplasia, and ureteral strictures, increases significantly, often necessitating endoscopic treatment.
As a result, these nations are experiencing a rise in urological procedures among older adults, leading healthcare facilities to adopt advanced flexible ureteroscopes that enable safer and less invasive interventions. With this shift, the need for ureteroscopes designed specifically for elderly patients with additional health conditions is expected to increase significantly.
The increasing preference for disposable ureteroscopes is unlocking substantial growth opportunities in the global market. These single-use devices present notable benefits compared to their reusable counterparts, such as minimizing the risk of cross-contamination, eliminating the need for sterilization, and reducing long-term maintenance expenses. With healthcare providers placing greater emphasis on patient safety and operational efficiency, the adoption of disposable instruments is gaining momentum.
These innovations underscore a wider shift within the medical industry toward flexible, hygienic, and cost-effective solutions, particularly suited for outpatient and ambulatory surgeries.
North America holds a dominant share in the global ureteroscope market, driven by advanced healthcare infrastructure, early adoption of innovative technologies, and a high prevalence of urolithiasis. According to the National Kidney Foundation, over 1 in 10 Americans will develop kidney stones during their lifetime, significantly boosting demand for ureteroscopic procedures. The U.S. is witnessing rising adoption of disposable digital ureteroscopes, such as Boston Scientific’s LithoVue, due to improved infection control and reduced reprocessing costs.
Additionally, favorable reimbursement policies and a growing shift toward outpatient urology services in ambulatory surgical centers (ASCs) further support market growth. Canada is also expanding urological services with investments in minimally invasive surgical tools across public healthcare systems. The region’s robust focus on research and clinical trials for urology devices enhances innovation, attracting global players to invest in product development and regional expansion.
sales@straitsresearch.com